Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Simon

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
Neurology|January 23, 2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBMBogdana Suchorska, Nathalie L Jansen, Jennifer Linn, et al.
Journal of Neuropathology and Experimental Neurology|May 15, 2010
Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutationAchim Temme, Kathrin D Geiger, Ralf Wiedemuth, et al.
Acta Neuropathologica|November 20, 2010
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomasChristian Hartmann, Bettina Hentschel, Wolfgang Wick, et al.
Translational Oncology|December 19, 2016
MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motilityDaniel Luxen, Gerrit H Gielen, Anke Waha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?Michael Weller, Hilmar Berger, Christian Hartmann, et al.
BJC Reports|April 15, 2026
Molecular targeting of the meningioma cell signaling circuit reveals drug vulnerabilities including synergy between sulforaphane and focal adhesion kinase inhibitionMichelle C Schwab, Yasmin Kocas, Sarah Gendreizig, et al.
The American Journal of Pathology|June 13, 2012
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomasTim Müller, Marco Gessi, Anke Waha, et al.
Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomasAnna von dem Knesebeck, Jörg Felsberg, Anke Waha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2015
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PETSied Kebir, Rolf Fimmers, Norbert Galldiks, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
Neurology|January 23, 2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBMBogdana Suchorska, Nathalie L Jansen, Jennifer Linn, et al.
Journal of Neuropathology and Experimental Neurology|May 15, 2010
Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutationAchim Temme, Kathrin D Geiger, Ralf Wiedemuth, et al.
Acta Neuropathologica|November 20, 2010
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomasChristian Hartmann, Bettina Hentschel, Wolfgang Wick, et al.
Translational Oncology|December 19, 2016
MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motilityDaniel Luxen, Gerrit H Gielen, Anke Waha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?Michael Weller, Hilmar Berger, Christian Hartmann, et al.
BJC Reports|April 15, 2026
Molecular targeting of the meningioma cell signaling circuit reveals drug vulnerabilities including synergy between sulforaphane and focal adhesion kinase inhibitionMichelle C Schwab, Yasmin Kocas, Sarah Gendreizig, et al.
The American Journal of Pathology|June 13, 2012
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomasTim Müller, Marco Gessi, Anke Waha, et al.
Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomasAnna von dem Knesebeck, Jörg Felsberg, Anke Waha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2015
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PETSied Kebir, Rolf Fimmers, Norbert Galldiks, et al.
Pageof 19